Latest news
Loading news…
Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Kineta was acquired by TuHURA Biosciences in 2024.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
15
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Seattle, Washington, United States
15
professional contacts at Kineta
Contact execs at Kineta →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Kineta
Loading news…
FAQs about Kineta
People who checked this page also checked these
Browse the full Acquirezy directory.